Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Lymph Edema-induced Reticulation Subtraction Based on Computerized Tomography.

NCT03523494 is registered in ClinicalTrials.gov with Ulsan University Hospital as lead sponsor.

NCT NCT03523494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03523494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Lymph Edema-induced Reticulation Subtraction Based on Computerized Tomography.
Lead sponsor
Ulsan University Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
March 30, 2018
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ct, lymphedema, secondary lymphedema